Use of prostaglandin E2 vaginal suppositories in third-trimester fetal demise.
A retrospective analysis of eight cases of third-trimester fetal demise managed with prostaglandin E2 vaginal suppositories (PGE2) is presented. Management included laminaria insertion prior to induction and an initial lower dosage of PGE2. No cases of uterine rupture or cervicovaginal lacerations were encountered. A summary of the literature as it relates to PGE2 vaginal suppository use in third-trimester fetal demise is included.
Martin
R W
RW
Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson.
Helman
N S
NS
Martin
J N
JN
Morrison
J C
JC
D000293:Adolescent; D000328:Adult; D005260:Female; D005313:Fetal Death; D006801:Humans; D010570:Pessaries; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*; D012189:Retrospective Studies
D011459:Prostaglandins E, Synthetic